173 related articles for article (PubMed ID: 23922910)
1. A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milk.
Kelly LE; Chaudhry SA; Rieder MJ; 't Jong G; Moretti ME; Lausman A; Ross C; Berger H; Carleton B; Hayden MR; Madadi P; Koren G
PLoS One; 2013; 8(7):e70073. PubMed ID: 23922910
[TBL] [Abstract][Full Text] [Related]
2. Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers.
Sistonen J; Madadi P; Ross CJ; Yazdanpanah M; Lee JW; Landsmeer ML; Nauta M; Carleton BC; Koren G; Hayden MR
Clin Pharmacol Ther; 2012 Apr; 91(4):692-9. PubMed ID: 22398969
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study.
Madadi P; Ross CJ; Hayden MR; Carleton BC; Gaedigk A; Leeder JS; Koren G
Clin Pharmacol Ther; 2009 Jan; 85(1):31-5. PubMed ID: 18719619
[TBL] [Abstract][Full Text] [Related]
4. Establishing causality of CNS depression in breastfed infants following maternal codeine use.
Madadi P; Shirazi F; Walter FG; Koren G
Paediatr Drugs; 2008; 10(6):399-404. PubMed ID: 18998750
[TBL] [Abstract][Full Text] [Related]
5. Genetic transmission of cytochrome P450 2D6 (CYP2D6) ultrarapid metabolism: implications for breastfeeding women taking codeine.
Madadi P; Ciszkowski C; Gaedigk A; Leeder JS; Teitelbaum R; Chitayat D; Koren G
Curr Drug Saf; 2011 Feb; 6(1):36-9. PubMed ID: 21241245
[TBL] [Abstract][Full Text] [Related]
6. Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia.
Lam J; Kelly L; Ciszkowski C; Landsmeer ML; Nauta M; Carleton BC; Hayden MR; Madadi P; Koren G
J Pediatr; 2012 Jan; 160(1):33-7.e2. PubMed ID: 21880331
[TBL] [Abstract][Full Text] [Related]
7. Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine.
Madadi P; Koren G; Cairns J; Chitayat D; Gaedigk A; Leeder JS; Teitelbaum R; Karaskov T; Aleksa K
Can Fam Physician; 2007 Jan; 53(1):33-5. PubMed ID: 17872605
[TBL] [Abstract][Full Text] [Related]
8. Increased DNA Methylation of ABCB1, CYP2D6, and OPRM1 Genes in Newborn Infants of Methadone-Maintained Opioid-Dependent Mothers.
McLaughlin P; Mactier H; Gillis C; Hickish T; Parker A; Liang WJ; Osselton MD
J Pediatr; 2017 Nov; 190():180-184.e1. PubMed ID: 28867064
[TBL] [Abstract][Full Text] [Related]
9. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome.
Wachman EM; Hayes MJ; Brown MS; Paul J; Harvey-Wilkes K; Terrin N; Huggins GS; Aranda JV; Davis JM
JAMA; 2013 May; 309(17):1821-7. PubMed ID: 23632726
[TBL] [Abstract][Full Text] [Related]
10. Putative association of ABCB1 2677G>T/A with oxycodone-induced central nervous system depression in breastfeeding mothers.
Lam J; Kelly L; Matok I; Ross CJ; Carleton BC; Hayden MR; Madadi P; Koren G
Ther Drug Monit; 2013 Aug; 35(4):466-72. PubMed ID: 23783165
[TBL] [Abstract][Full Text] [Related]
11. The Implausibility of Neonatal Opioid Toxicity from Breastfeeding.
Zipursky J; Juurlink DN
Clin Pharmacol Ther; 2020 Nov; 108(5):964-970. PubMed ID: 32378749
[TBL] [Abstract][Full Text] [Related]
12. Risk to the breast-fed neonate from codeine treatment to the mother: a quantitative mechanistic modeling study.
Willmann S; Edginton AN; Coboeken K; Ahr G; Lippert J
Clin Pharmacol Ther; 2009 Dec; 86(6):634-43. PubMed ID: 19710640
[TBL] [Abstract][Full Text] [Related]
13. Genotypic screening of the main opiate-related polymorphisms in a cohort of 139 sickle cell disease patients.
Joly P; Gagnieu MC; Bardel C; Francina A; Pondarre C; Martin C
Am J Hematol; 2012 May; 87(5):534-6. PubMed ID: 22430884
[TBL] [Abstract][Full Text] [Related]
14. Molecular Basis of Cancer Pain Management: An Updated Review.
V Subramaniam A; Salem Yehya AH; Oon CE
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31547335
[TBL] [Abstract][Full Text] [Related]
15. The pharmacogenetics of codeine pain relief in the postpartum period.
Baber M; Chaudhry S; Kelly L; Ross C; Carleton B; Berger H; Koren G
Pharmacogenomics J; 2015 Oct; 15(5):430-5. PubMed ID: 25752520
[TBL] [Abstract][Full Text] [Related]
16. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study.
VanderVaart S; Berger H; Sistonen J; Madadi P; Matok I; Gijsen VM; de Wildt SN; Taddio A; Ross CJ; Carleton BC; Hayden MR; Koren G
Ther Drug Monit; 2011 Aug; 33(4):425-32. PubMed ID: 21743374
[TBL] [Abstract][Full Text] [Related]
17. Safety issues of maternal drug therapy during breastfeeding.
Berlin CM; Paul IM; Vesell ES
Clin Pharmacol Ther; 2009 Jan; 85(1):20-2. PubMed ID: 19092767
[TBL] [Abstract][Full Text] [Related]
18. Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers.
Lötsch J; von Hentig N; Freynhagen R; Griessinger N; Zimmermann M; Doehring A; Rohrbacher M; Sittl R; Geisslinger G
Pharmacogenet Genomics; 2009 Jun; 19(6):429-36. PubMed ID: 19514130
[TBL] [Abstract][Full Text] [Related]
19. Predicted activity of UGT2B7, ABCB1, OPRM1, and COMT using full-gene haplotypes and their association with the CYP2D6-inferred metabolizer phenotype.
Wendt FR; Sajantila A; Budowle B
Forensic Sci Int Genet; 2018 Mar; 33():48-58. PubMed ID: 29190510
[TBL] [Abstract][Full Text] [Related]
20. A cost-effectiveness analysis of maternal CYP2D6 genetic testing to guide treatment for postpartum pain and avert infant adverse events.
Moretti ME; Lato DF; Berger H; Koren G; Ito S; Ungar WJ
Pharmacogenomics J; 2018 May; 18(3):391-397. PubMed ID: 28696420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
